800634991	800634991	CD	B-NP	O
|	|	NNP	I-NP	O
WUOAH	WUOAH	NNP	I-NP	O
|	|	VBD	B-VP	O
56611655	56611655	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
341847	341847	CD	B-NP	O
|	|	CC	I-NP	O
10/9/2000	10/9/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/9/2000	10/9/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
CARDIOLOGY	CARDIOLOGY	NNP	B-NP	O
RII	RII	NNP	I-NP	O
TERMROA	TERMROA	NNP	I-NP	O
UNIVERSITY	UNIVERSITY	NNP	I-NP	O
OF	OF	IN	B-PP	O
SERVICE	SERVICE	NNP	B-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
53	53	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1986	1986	CD	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
not	not	RB	B-NP	O
well	well	RB	I-NP	O
controlled	controlled	JJ	I-NP	O
,	,	,	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
some	some	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
admits	admit	VBZ	B-VP	O
to	to	TO	B-PP	O
having	have	VBG	B-VP	O
injuried	injurie	VBN	I-VP	O
her	her	PRP$	B-NP	O
knee	knee	NN	I-NP	O
while	while	IN	B-SBAR	O
climbing	climb	VBG	B-VP	O
a	a	DT	B-NP	O
mountain	mountain	NN	I-NP	O
in	in	IN	B-PP	O
Vocouta	Vocouta	NNP	B-NP	O
Na	Na	NNP	I-NP	O
Hisa	Hisa	NNP	I-NP	O
almost	almost	RB	B-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
knee	knee	NN	I-NP	O
immobilizer	immobilizer	NN	I-NP	O
for	for	IN	B-PP	O
that	that	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
much	much	JJ	B-NP	O
ambulation	ambulation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
cook	cook	VB	I-VP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
foods	food	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
immobility	immobility	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
says	say	VBZ	B-VP	O
the	the	DT	B-NP	O
swelling	swelling	NN	I-NP	O
then	then	RB	B-ADVP	O
occurred	occur	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
attempted	attempt	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
helped	help	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
now	now	RB	B-VP	O
present	present	VBP	I-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Insulin	Insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
for	for	IN	B-PP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
not	not	RB	O	O
well	well	RB	B-ADJP	O
controlled	controlled	JJ	B-NP	O
,	,	,	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
inferior	inferior	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
1986	1986	CD	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mitral	mitral	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Elavil	Elavil	NN	B-NP	O
50	50	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
30	30	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
Tiazac	Tiazac	NN	B-NP	O
180	180	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
50	50	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
,	,	,	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Required	Require	VBN	B-VP	O
80	80	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
intravenous	intravenous	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
to	to	TO	B-VP	O
twice	twice	VB	I-VP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
increase	increase	VBP	B-VP	O
that	that	IN	B-SBAR	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
200	200	CD	B-NP	O
intravenous	intravenous	JJ	I-NP	O
Lasix	Lasix	NNP	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
added	add	VBD	B-VP	O
500	500	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
of	of	IN	B-PP	O
Diuril	Diuril	NNP	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
claustrophobia	claustrophobia	NN	B-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
July	July	NNP	B-NP	O
required	require	VBD	B-VP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
clonidine	clonidine	NN	B-NP	O
for	for	IN	B-PP	O
not	not	RB	B-NP	O
well	well	RB	I-NP	O
controlled	controlled	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
180s	180s	CD	I-NP	O
and	and	CC	I-NP	O
190s/100	190s/100	CD	I-NP	O
,	,	,	O	O
.	.	.	O	O

Changed	Changed	NNP	B-NP	O
Captopril	Captopril	NNP	I-NP	O
to	to	TO	B-VP	O
ramipril	ramipril	VB	I-VP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
lipophilic	lipophilic	JJ	I-NP	O
absorption	absorption	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
July	July	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
and	and	CC	O	O
Clonidine	Clonidine	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
2.5	2.5	CD	B-NP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
hyperproliferative	hyperproliferative	JJ	I-NP	O
normal	normal	JJ	I-NP	O
MCV	MCV	NN	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
level	level	NN	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2000	2000	CD	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
2-3	2-3	NN	B-NP	O
+	+	SYM	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
showed	show	VBD	B-VP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
continued	continue	VBN	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
somewhat	somewhat	RB	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

Sputum	Sputum	NNP	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
gram	gram	NN	I-NP	O
stain	stain	NN	I-NP	O
showing	show	VBG	B-VP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
gram	gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
in	in	IN	B-PP	O
clusters	cluster	NNS	B-NP	O
and	and	CC	I-NP	O
chains	chain	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
culture	culture	NN	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
March	March	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
creatinine	creatinine	NN	B-NP	O
to	to	TO	B-PP	O
2.6	2.6	CD	B-NP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Continued	Continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
Norvasc	Norvasc	NN	I-NP	O
and	and	CC	I-NP	O
Clonidine	Clonidine	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
3.0	3.0	CD	B-NP	O
.	.	.	O	O

Held	Held	RB	B-ADVP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
orthostatic	orthostatic	JJ	B-ADJP	O
.	.	.	O	O

MRI/MRA	MRI/MRA	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Elavil	Elavil	NN	B-NP	O
50	50	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.h.s.	q.h.s.	FW	I-ADVP	O
,	,	,	O	O
Ecasa	Ecasa	NNP	B-NP	O
325	325	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
milliliter	milliliter	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NNP	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
sublingual	sublingual	JJ	I-NP	I-protein
q5min	q5min	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.h.s.	q.h.s.	FW	I-ADVP	O
,	,	,	O	O
Tiazac	Tiazac	NNP	B-NP	O
180	180	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
50	50	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Humulogue	Humulogue	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	RB	B-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Bumex	Bumex	NNP	B-NP	O
10	10	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
With	With	IN	B-SBAR	O
Dr.	Dr.	NNP	B-NP	O
Dayton	Dayton	NNP	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Woodhead	Woodhead	NNP	I-NP	O
whenever	whenever	WRB	B-ADVP	O
appointment	appointment	NN	B-NP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LEOPOLDO	LEOPOLDO	NNP	B-NP	O
STECHER	STECHER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
FO39	FO39	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DEMETRIUS	DEMETRIUS	NNP	B-NP	O
BEFORT	BEFORT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
YT8	YT8	NNP	I-NP	O
JT483/1162	JT483/1162	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
33614	33614	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

CEZDBX18JF	CEZDBX18JF	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/23	7/23	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/21	6/21	CD	B-NP	O

